Our study shows that TNFR-Fc targeting TNF-α, and applied intraperitoneally, produces a beneficial effect in an LPS-induced mouse model of ALI, reducing the inflammatory response and lung tissue destruction [15]. The gene discussed is TNF; the disease is acute respiratory distress syndrome.